Jennifer Rosenbluth, MD, PhD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW
San Francisco CA 94143
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Princeton UniversityAB
    Vanderbilt University School of MedicineMD
    Vanderbilt University School of MedicinePhD
    Massachusetts General HospitalInternal Medicine
    Dana-Farber Cancer InstituteMedical Oncology
    Collapse Awards and Honors
    Vanderbilt University2011Dean's Award for Research
    Vanderbilt University2011John G. Coniglio Prize for Excellence in Biochemistry
    Dana-Farber Cancer Institute2014Leadership Council Fellow
    American Society of Clinical Oncology2017  - 2018Young Investigator Award
    American Cancer Society2017  - 2019Postdoctoral Fellowship
    Dana-Farber Cancer Institute2019  - 2020Eleanor and Miles Shore Award
    Susan G. Komen Foundation2019Career Catalyst Research Grant
    Dana-Farber Cancer Institute2020  - 2021Sidney Farber Scholar
    Terri Brodeur Breast Cancer Foundation2021Fellowship Award
    Breast Cancer Alliance2021Young Investigator Grant
    Doris Duke Charitable Foundation2021Clinical Scientist Development Award

    Collapse Overview 
    Collapse Overview
    Jennifer Rosenbluth, MD, PhD, is a medical oncologist who specializes in breast cancer, an Assistant Professor in the Department of Medicine, and a member of the Breast Oncology Program. The research in her laboratory utilizes three-dimensional organoid cultures of premalignant and tumorigenic breast tissues to identify heterogeneous populations of cells that promote cancer development and progression.
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer. Am J Clin Oncol. 2021 09 01; 44(9):449-455. Hirko KA, Regan MM, Remolano MC, Schlossman J, Harrison B, Yeh E, Jacene H, Nakhlis F, Block C, Rosenbluth JM, Garrido-Castro AC, Overmoyer BA. PMID: 34149037.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021 04; 16(4):1936-1965. Dekkers JF, van Vliet EJ, Sachs N, Rosenbluth JM, Kopper O, Rebel HG, Wehrens EJ, Piani C, Visvader JE, Verissimo CS, Boj SF, Brugge JS, Clevers H, Rios AC. PMID: 33692550.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    3. Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing. Cell Rep. 2020 12 29; 33(13):108566. Li CM, Shapiro H, Tsiobikas C, Selfors LM, Chen H, Rosenbluth J, Moore K, Gupta KP, Gray GK, Oren Y, Steinbaugh MJ, Guerriero JL, Pinello L, Regev A, Brugge JS. PMID: 33378681.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    4. Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program. Breast J. 2020 09; 26(9):1688-1694. White RE, Warren L, Nakhlis F, Rosenbluth J, Bellon J, Block C, Overmoyer B. PMID: 32875655.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. Breast Cancer Res Treat. 2020 Jun; 181(2):383-390. Jacene HA, DiPiro PJ, Bellon J, Hu J, Cheng SC, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth JM, Yeh E, Overmoyer B. PMID: 32318957.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nat Commun. 2020 04 06; 11(1):1711. Rosenbluth JM, Schackmann RCJ, Gray GK, Selfors LM, Li CM, Boedicker M, Kuiken HJ, Richardson A, Brock J, Garber J, Dillon D, Sachs N, Clevers H, Brugge JS. PMID: 32249764.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    7. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat Biotechnol. 2020 02; 38(2):199-209. Sarkizova S, Klaeger S, Le PM, Li LW, Oliveira G, Keshishian H, Hartigan CR, Zhang W, Braun DA, Ligon KL, Bachireddy P, Zervantonakis IK, Rosenbluth JM, Ouspenskaia T, Law T, Justesen S, Stevens J, Lane WJ, Eisenhaure T, Lan Zhang G, Clauser KR, Hacohen N, Carr SA, Wu CJ, Keskin DB. PMID: 31844290.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    8. Inflammatory Breast Cancer: a Separate Entity. Curr Oncol Rep. 2019 08 15; 21(10):86. Rosenbluth JM, Overmoyer BA. PMID: 31414257.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion. Cell Metab. 2019 05 07; 29(5):1166-1181.e6. Harris IS, Endress JE, Coloff JL, Selfors LM, McBrayer SK, Rosenbluth JM, Takahashi N, Dhakal S, Koduri V, Oser MG, Schauer NJ, Doherty LM, Hong AL, Kang YP, Younger ST, Doench JG, Hahn WC, Buhrlage SJ, DeNicola GM, Kaelin WG, Brugge JS. PMID: 30799286.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    10. Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade. Clin Breast Cancer. 2019 04; 19(2):146-155. Jacene HA, Youn T, DiPiro PJ, Hu J, Cheng SC, Franchetti Y, Shah H, Bellon JR, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth J, Yeh E, Overmoyer B, Dana-Farber Cancer Institute Inflammatory Breast Cancer Program . PMID: 30584057.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. Clin Cancer Res. 2017 Aug 01; 23(15):4035-4045. Jovanovic B, Mayer IA, Mayer EL, Abramson VG, Bardia A, Sanders ME, Kuba MG, Estrada MV, Beeler JS, Shaver TM, Johnson KC, Sanchez V, Rosenbluth JM, Dillon PM, Forero-Torres A, Chang JC, Meszoely IM, Grau AM, Lehmann BD, Shyr Y, Sheng Q, Chen SC, Arteaga CL, Pietenpol JA. PMID: 28270498.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCellsCTClinical Trials
    12. p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network. Cell Rep. 2016 Mar 15; 14(10):2289-300. Marshall CB, Mays DJ, Beeler JS, Rosenbluth JM, Boyd KL, Santos Guasch GL, Shaver TM, Tang LJ, Liu Q, Shyr Y, Venters BJ, Magnuson MA, Pietenpol JA. PMID: 26947080.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCells
    13. Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis. Proc Natl Acad Sci U S A. 2011 Feb 01; 108(5):2076-81. Rosenbluth JM, Mays DJ, Jiang A, Shyr Y, Pietenpol JA. PMID: 21245298.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    14. ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy. Mol Cancer. 2010 Apr 29; 9:95. Eby KG, Rosenbluth JM, Mays DJ, Marshall CB, Barton CE, Sinha S, Johnson KN, Tang L, Pietenpol JA. PMID: 20429933.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    15. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clin Cancer Res. 2010 Jan 15; 16(2):681-90. Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, Schneider RJ, Formenti SC, Caprioli RM, Pietenpol JA. PMID: 20068102.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    16. Evaluation of p63 and p73 antibodies for cross-reactivity. Cell Cycle. 2009 Nov 15; 8(22):3702-6. Rosenbluth JM, Johnson K, Tang L, Triplett T, Pietenpol JA. PMID: 19855172.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    17. mTOR regulates autophagy-associated genes downstream of p73. Autophagy. 2009 Jan; 5(1):114-6. Rosenbluth JM, Pietenpol JA. PMID: 19001857.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    18. The jury is in: p73 is a tumor suppressor after all. Genes Dev. 2008 Oct 01; 22(19):2591-5. Rosenbluth JM, Pietenpol JA. PMID: 18832062.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    19. A gene signature-based approach identifies mTOR as a regulator of p73. Mol Cell Biol. 2008 Oct; 28(19):5951-64. Rosenbluth JM, Mays DJ, Pino MF, Tang LJ, Pietenpol JA. PMID: 18678646.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    20. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci. 2006 Nov 22; 26(47):12339-50. Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, Oh L, Rasband M, Lappe-Siefke C, Yu K, Ornitz DM, Nave KA, Bansal R. PMID: 17122059.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    21. No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta. Mol Cell Biol. 2000 Oct; 20(20):7706-15. Harroch S, Palmeri M, Rosenbluth J, Custer A, Okigaki M, Shrager P, Blum M, Buxbaum JD, Schlessinger J. PMID: 11003666.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    Jennifer's Networks
    Concepts (205)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _